GLRX3, a key regulatory protein for iron-sulfur clusters, is abnormally overexpressed in liver cancer patients, and its overexpression facilitates iron-sulfur cluster assembly and transport, thereby disrupting metabolic balance and promoting tumor cell growth and metastasis. Here, GLRX3 is linked to liver cancer.